India’s customs department has joined the health ministry in challenging the sale of nicotine pouches at Adani Group-operated airport duty-free shops. The authority argues that duty-free status does not bypass Indian regulatory rules. The dispute, currently pending in the Mumbai High Court, highlights potential risks to the company's retail operations at its airport hubs.
India’s customs department has formally opposed the sale of nicotine pouches at airport duty-free shops operated by the Adani Group. In a recent filing before the Mumbai High Court, the department supported the health ministry’s position that these products are not permitted for sale, regardless of their location within international departure zones.
Regulatory Stance on Duty-Free Operations
The central issue in this legal challenge is whether the tax-free nature of airport duty-free zones provides immunity from national product safety regulations. The Adani Group has argued that these shops operate beyond the scope of standard domestic rules, as the products are intended for consumption outside India. However, the customs authority’s latest filing explicitly states that the designation of being outside customs frontiers for tax purposes does not grant freedom from regulatory compliance. The department has labeled the company's defense regarding the international transit of these goods as untenable.
Impact on Airport Retail and Expansion
The Adani Group is a major player in the Indian aviation infrastructure sector, currently operating eight airports across the country. The company has also announced plans for a significant expansion in its airport infrastructure business, with investments estimated at $11 billion. While the immediate financial impact of the disputed nicotine pouch imports—valued at over $35,000 since August—is relatively small compared to the company’s total revenue, the legal battle brings increased regulatory scrutiny to its retail and commercial operations.
Broader Regulatory Context
Nicotine pouches have gained significant popularity in international markets, with major brands seeing substantial sales growth. In India, however, these products face strict oversight. The health ministry has previously flagged them as illegal, and this ongoing court dispute underscores the challenges of introducing newer categories of nicotine products into the highly regulated Indian market. This case could establish a precedent for how consumer goods are regulated within airport duty-free zones, which are often treated as distinct environments for taxation and trade.
The Mumbai High Court is scheduled to hear the matter next on July 28, 2026. Investors and stakeholders will be tracking the outcome to see if the court enforces a stricter regulatory regime on items sold in international departure areas, as this could impact the product mix and operational compliance of duty-free retailers across the country.